Skip to main content

Table 1 Clinicopathological characteristics of the study cohort

From: YRNA expression predicts survival in bladder cancer patients

  Normal BCA
n = 30 n = 88
Sex
 Male 22 (73%) 70 (79.5%)
 Female 8 (27%) 18 (20.5%)
Age
 Mean 66.3 69.1
 Range 43–81 40–91
Staging
 pT-stage
  pTa n.a. 13 (14.8%)
  pTis n.a. 13 (14.8%)
  pT1 n.a. 18 (20.5%)
  pT2 n.a. 12 (13.6%)
  pT3 n.a. 15 (17.0%)
  pT4 n.a. 17 (19.3%)
 Lymph node metastasis n.a. 23 (26.1%)
 Distant metastasis n.a. 2 (2.3%)
Grading
 grade 1 n.a. 9 (10.2%)
 grade 2 n.a. 31 (35.2%)
 grade 3 n.a. 48 (54.5%)